SL

Spiros Liras

Venture partner at Apple Tree Partners

Brookline, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

Massachusetts

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Early Stage Investment
Start-up Ventures
Venture Management
Drug Development
Drug Design
Medicinal Chemistry
Organic Chemistry
Drug Discovery
Pharmaceutical Industry

Education

Lists including Spiros

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Deep Apple Therapeutics

Series A

Total Funding: $52M

Initial Therapeutics

Series A

Total Funding: $75M

Nereid Therapeutics

Series A

Total Funding: $50M

Work Experience

A(
ATP (Apple Tree Partners)

2019

  • Deep Apple Therapeutics; Co-Founder, CEO and Board Director

    2021

  • Nereid Therapeutics; Co-Founder, founding CEO, Board Director

    2020

  • Intitial Therapeutics; Co-Founder, CEO and Board Director

    2020

  • Nine Square Therapeutics; Co-Founder, Founding CEO and Board Director

    2020

  • Venture Partner

    2019

Uo
University of California, San Francisco, Department of Pharmaceutical Chemistry

2019

  • Adjunct Full Professor

    2019

B
Biogen

2018 - 2019

  • Head, External Portfolio Innovation Unit

    2018 - 2019

P
Pfizer

2009 - 2018

  • VP Medicinal Chemistry

    2017 - 2018

  • VP, CVMED Medicinal Chemistry

    2011 - 2017

  • Executive Director

    2009 - 2011

    Head of CVMED medicinal chemistry

P
Pfizer

1994 - 2008

  • Senior Director, Neuroscience medicinal chemistry

    2004 - 2008

  • Medicinal chemist

    1994 - 2004